微创医疗发布公告,微创医疗科学有限公司董事会按公司于2023年6月19日采纳的股份计划向集团二十四名合资格参与者授出合共340.85万份购股权以认购最多合共340.85万股每股面值0.00001美元的普通股,占公司于本公告日期已发行股本约0.18%,惟须待承授人接纳购股权后,方可作实。【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.